Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
暂无分享,去创建一个
T. Triche | E. Davicioni | S. Donaldson | D. Rodeberg | S. Skapek | D. Hawkins | W. Meyer | E. Lyden | D. Parham | A. Hayes-Jordan | K. Brown | N. Garcia-Henriquez
[1] Zhuo Li,et al. Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades , 2010, Cancer.
[2] P. Sorensen,et al. Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group. , 2009, The American journal of pathology.
[3] D. Rickman,et al. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays , 2008, Oncogene.
[4] Y. Yamazaki,et al. Gene expression profile changes correlated with lymph node metastasis in oral squamous cell carcinoma , 2008, Odontology.
[5] James R. Anderson,et al. Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M. Stevens,et al. Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: an up-front window study in newly diagnosed children with high-risk metastatic disease. , 2008, European journal of cancer.
[7] James R. Anderson,et al. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] T. Triche,et al. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. , 2006, Cancer research.
[9] M. Carli,et al. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Tada,et al. Gene-Expression Profile Changes Correlated with Tumor Progression and Lymph Node Metastasis in Esophageal Cancer , 2004, Clinical Cancer Research.
[11] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[12] R. Pollock,et al. Soft Tissue Sarcomas , 2001, CA: a cancer journal for clinicians.
[13] J. Meza,et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG. , 2001, International journal of radiation oncology, biology, physics.
[14] James R. Anderson,et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] James R. Anderson,et al. Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V , 2001, Journal of pediatric hematology/oncology.
[16] E. Wiener,et al. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). , 2000, Journal of pediatric surgery.
[17] A. Pappo,et al. Biology and therapy of pediatric rhabdomyosarcoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[19] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[20] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[21] James R. Anderson,et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] A. Auquier,et al. Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop. , 1991, Medical and Pediatric Oncology.
[23] D.,et al. Regression Models and Life-Tables , 2022 .